1-3 of 3
Changping Li, MD
Close
Sort by
Journal Articles

Chemo-Resistance in Diffuse Large Cell Lymphoma: Novel Drug Combinations Targeting NFAT/NF-Kb Growth/Survival/Chemo-Resistance Signaling Pathways in Validated Novel Experimental Systems

Lan V Pham, PhD, Archito T. Tamayo, MS, Changping Li, MD, John Lee, MD, Luis Fayad, MD, Richard J. Ford, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1428.
https://doi.org/10.1182/blood.V118.21.1428.1428
Published: 2011
Journal Articles

Single-Agent Bruton's Tyrosine Kinase (Btk) Inhibitor and Single-Agent Carfilzomib Induce Cell Apoptosis, Arrest Cell Growth and Downregulate NF-Kb Activity In Mantle Cell Lymphoma

Zhishuo Ou, MD, Lan V Pham, PhD, Liang Zhang, MD, PhD, Archito T. Tamayo, MS, John Lee, MD, Kejie Zhang, MD, PhD, Jacqueline Wang, James Phan, Changping Li, MD, Luhong Sun, MD, PhD, Richard J. Ford, MD, PhD, Michael Wang, MD
Journal: Blood
Blood (2011) 118 (21): 4971.
https://doi.org/10.1182/blood.V118.21.4971.4971
Published: 2011
Journal Articles

A Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients with Chronic Myeloid Leukemia (CML) and Minimal Residual Disease.

Jorge Cortes, MD, James M. Reuben, MD, David Scheinberg, MD, Bang-Ning Lee, PhD, Hui Gao, PhD, Changping Li, MD, Rosemary Mazanet, MD, Dan Jones, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2006) 108 (11): 2196.
https://doi.org/10.1182/blood.V108.11.2196.2196
Published: 2006